APO RESEARCH · REPORT
Clinical Trial Imaging
Medical imaging now plays a vital role in clinical trials. Reputation and credibility in Clinical Trials are paramount. Confidence is key which demands the highest quality specialists with unbiased and professional imaging support.
Product & engineering
Understand the product.
Medical imaging now plays a vital role in clinical trials. Reputation and credibility in Clinical Trials are paramount. Confidence is key which demands the highest quality specialists with unbiased and professional imaging support.
Selected research
Industry Growth & Trends
Global Clinical Trial Imaging Industry Growth and Trends Forecast to 2032
Market perspective
Medical imaging now plays a vital role in clinical trials. Reputation and credibility in Clinical Trials are paramount. Confidence is key which demands the highest quality specialists with unbiased and professional imaging support.
According to APO Research, the global Clinical Trial Imaging market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
Report Scope
Read the full market overview
This report provides a structured, data-driven view of the global Clinical Trial Imaging market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Clinical Trial Imaging market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Clinical Trial Imaging market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Clinical Trial Imaging.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Clinical Trial Imaging market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Clinical Trial Imaging Market by Company
ICON
ERT
McLaren
Bioclinica
Parexel
BioTelemetry
ProScan Imaging
Imaging Endpoints
Radiant Sage
Micron, Inc.
Intrinsic Imaging
Median Technologies
Cardiovascular Imaging Technologies
Banook Medical
IXICO
Clinical Trial Imaging Segment by Type
In-house Imaging Service
Central Imaging Service
Clinical Trial Imaging Segment by Application
Pharmaceutical Companies
Biotechnology Companies
Academic Institutes
Others
Clinical Trial Imaging Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Clinical Trial Imaging market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Clinical Trial Imaging and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Clinical Trial Imaging.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Clinical Trial Imaging companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- In-house Imaging Service
- Central Imaging Service
Applications
- Pharmaceutical Companies
- Biotechnology Companies
- Academic Institutes
- Others
Companies covered
- ICON
- ERT
- McLaren
- Bioclinica
- Parexel
- BioTelemetry
- ProScan Imaging
- Imaging Endpoints
- Radiant Sage
- Micron, Inc.
- Intrinsic Imaging
- Median Technologies
- Cardiovascular Imaging Technologies
- Banook Medical
- IXICO
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Clinical Trial Imaging Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Clinical Trial Imaging Market Size by Region (2021-2032)
- 1.4.1 Global Clinical Trial Imaging Market Size by Region (2021-2026)
- 1.4.2 Global Clinical Trial Imaging Market Size by Region (2027-2032)
- 1.5 Key Regions Clinical Trial Imaging Market Size (2021-2032)
- 1.5.1 North America Clinical Trial Imaging Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Clinical Trial Imaging Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Clinical Trial Imaging Market Size Growth Rate (2021-2032)
- 1.5.4 South America Clinical Trial Imaging Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Clinical Trial Imaging Market Size Growth Rate (2021-2032)
2 Clinical Trial Imaging Market by Type
- 2.1 Type Introduction
- 2.1.1 In-house Imaging Service
- 2.1.2 Central Imaging Service
- 2.2 Global Clinical Trial Imaging Market Size by Type
- 2.2.1 Global Clinical Trial Imaging Market Size Overview by Type (2021-2032)
- 2.2.2 Global Clinical Trial Imaging Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Clinical Trial Imaging Market Size Forecasted by Type (2027-2032)
- 2.3 Global Clinical Trial Imaging Market Size by Regions
- 2.3.1 North America Clinical Trial Imaging Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Clinical Trial Imaging Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Clinical Trial Imaging Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Clinical Trial Imaging Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Clinical Trial Imaging Market Size Breakdown by Type (2021-2026)
3 Clinical Trial Imaging Market by Application
- 3.1 Type Introduction
- 3.1.1 Pharmaceutical Companies
- 3.1.2 Biotechnology Companies
- 3.1.3 Academic Institutes
- 3.1.4 Others
- 3.2 Global Clinical Trial Imaging Market Size by Application
- 3.2.1 Global Clinical Trial Imaging Market Size Overview by Application (2021-2032)
- 3.2.2 Global Clinical Trial Imaging Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Clinical Trial Imaging Market Size Forecasted by Application (2027-2032)
- 3.3 Global Clinical Trial Imaging Market Size by Regions
- 3.3.1 North America Clinical Trial Imaging Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Clinical Trial Imaging Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Clinical Trial Imaging Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Clinical Trial Imaging Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Clinical Trial Imaging Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Clinical Trial Imaging Industry Trends
- 4.2 Clinical Trial Imaging Industry Drivers
- 4.3 Clinical Trial Imaging Industry Opportunities and Challenges
- 4.4 Clinical Trial Imaging Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Clinical Trial Imaging Revenue (2021-2026)
- 5.2 Global Clinical Trial Imaging Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Clinical Trial Imaging Key Company Headquarters & Area Served
- 5.4 Global Clinical Trial Imaging Company, Product Type & Application
- 5.5 Global Clinical Trial Imaging Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Clinical Trial Imaging Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Clinical Trial Imaging Players Market Share by Revenue in 2025
- 5.6.3 2025 Clinical Trial Imaging Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 ICON
- 6.1.1 ICON Company Information
- 6.1.2 ICON Business Overview
- 6.1.3 ICON Clinical Trial Imaging Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 ICON Clinical Trial Imaging Product Portfolio
- 6.1.5 ICON Recent Developments
- 6.2 ERT
- 6.2.1 ERT Company Information
- 6.2.2 ERT Business Overview
- 6.2.3 ERT Clinical Trial Imaging Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 ERT Clinical Trial Imaging Product Portfolio
- 6.2.5 ERT Recent Developments
- 6.3 McLaren
- 6.3.1 McLaren Company Information
- 6.3.2 McLaren Business Overview
- 6.3.3 McLaren Clinical Trial Imaging Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 McLaren Clinical Trial Imaging Product Portfolio
- 6.3.5 McLaren Recent Developments
- 6.4 Bioclinica
- 6.4.1 Bioclinica Company Information
- 6.4.2 Bioclinica Business Overview
- 6.4.3 Bioclinica Clinical Trial Imaging Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Bioclinica Clinical Trial Imaging Product Portfolio
- 6.4.5 Bioclinica Recent Developments
- 6.5 Parexel
- 6.5.1 Parexel Company Information
- 6.5.2 Parexel Business Overview
- 6.5.3 Parexel Clinical Trial Imaging Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Parexel Clinical Trial Imaging Product Portfolio
- 6.5.5 Parexel Recent Developments
- 6.6 BioTelemetry
- 6.6.1 BioTelemetry Company Information
- 6.6.2 BioTelemetry Business Overview
- 6.6.3 BioTelemetry Clinical Trial Imaging Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 BioTelemetry Clinical Trial Imaging Product Portfolio
- 6.6.5 BioTelemetry Recent Developments
- 6.7 ProScan Imaging
- 6.7.1 ProScan Imaging Company Information
- 6.7.2 ProScan Imaging Business Overview
- 6.7.3 ProScan Imaging Clinical Trial Imaging Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 ProScan Imaging Clinical Trial Imaging Product Portfolio
- 6.7.5 ProScan Imaging Recent Developments
- 6.8 Imaging Endpoints
- 6.8.1 Imaging Endpoints Company Information
- 6.8.2 Imaging Endpoints Business Overview
- 6.8.3 Imaging Endpoints Clinical Trial Imaging Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Imaging Endpoints Clinical Trial Imaging Product Portfolio
- 6.8.5 Imaging Endpoints Recent Developments
- 6.9 Radiant Sage
- 6.9.1 Radiant Sage Company Information
- 6.9.2 Radiant Sage Business Overview
- 6.9.3 Radiant Sage Clinical Trial Imaging Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Radiant Sage Clinical Trial Imaging Product Portfolio
- 6.9.5 Radiant Sage Recent Developments
- 6.10 Micron, Inc.
- 6.10.1 Micron, Inc. Company Information
- 6.10.2 Micron, Inc. Business Overview
- 6.10.3 Micron, Inc. Clinical Trial Imaging Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Micron, Inc. Clinical Trial Imaging Product Portfolio
- 6.10.5 Micron, Inc. Recent Developments
- 6.11 Intrinsic Imaging
- 6.11.1 Intrinsic Imaging Company Information
- 6.11.2 Intrinsic Imaging Business Overview
- 6.11.3 Intrinsic Imaging Clinical Trial Imaging Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Intrinsic Imaging Clinical Trial Imaging Product Portfolio
- 6.11.5 Intrinsic Imaging Recent Developments
- 6.12 Median Technologies
- 6.12.1 Median Technologies Company Information
- 6.12.2 Median Technologies Business Overview
- 6.12.3 Median Technologies Clinical Trial Imaging Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 Median Technologies Clinical Trial Imaging Product Portfolio
- 6.12.5 Median Technologies Recent Developments
- 6.13 Cardiovascular Imaging Technologies
- 6.13.1 Cardiovascular Imaging Technologies Company Information
- 6.13.2 Cardiovascular Imaging Technologies Business Overview
- 6.13.3 Cardiovascular Imaging Technologies Clinical Trial Imaging Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 Cardiovascular Imaging Technologies Clinical Trial Imaging Product Portfolio
- 6.13.5 Cardiovascular Imaging Technologies Recent Developments
- 6.14 Banook Medical
- 6.14.1 Banook Medical Company Information
- 6.14.2 Banook Medical Business Overview
- 6.14.3 Banook Medical Clinical Trial Imaging Revenue, Global Share and Gross Margin (2021-2026)
- 6.14.4 Banook Medical Clinical Trial Imaging Product Portfolio
- 6.14.5 Banook Medical Recent Developments
- 6.15 IXICO
- 6.15.1 IXICO Company Information
- 6.15.2 IXICO Business Overview
- 6.15.3 IXICO Clinical Trial Imaging Revenue, Global Share and Gross Margin (2021-2026)
- 6.15.4 IXICO Clinical Trial Imaging Product Portfolio
- 6.15.5 IXICO Recent Developments
7 North America
- 7.1 North America Clinical Trial Imaging Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Clinical Trial Imaging Market Size by Country (2021-2026)
- 7.3 North America Clinical Trial Imaging Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Clinical Trial Imaging Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Clinical Trial Imaging Market Size by Country (2021-2026)
- 8.3 Europe Clinical Trial Imaging Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Clinical Trial Imaging Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Clinical Trial Imaging Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Clinical Trial Imaging Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Clinical Trial Imaging Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Clinical Trial Imaging Market Size by Country (2021-2026)
- 10.3 South America Clinical Trial Imaging Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Clinical Trial Imaging Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Clinical Trial Imaging Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Clinical Trial Imaging Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst